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This has had profound consequences for the evolution and the movement of antibiotic resistance genes. Of the top ten megacities (cities with ≥10 million population) eight are in Asia, the other two being Mexico City and New York. These megacities place huge demands on public health infrastructure, particularly in relation to sewage, drinking water, and overcrowding. In addition, the emerging economies are often heavy users of antimicrobials in both medicine and agriculture, which, combined with the deficits in public health infrastructure, has resulted in very high rates of resistance to antibiotics, especially among Gram-negative bacteria.
Global mobility has changed dramatically in the last 15 years. Travel by air has increased to the extent that, in 2012, >5000 billion revenue passenger-kilometres were recorded by the International Civil Aviation Organization. 2 Passengers carry Gram-negative bacteria in their bowel flora, particularly Escherichia coli and Klebsiella spp. Consequently there is increasing exposure of populations all around the world to resistant bacteria arising in the emerging economies. The role of the environment in the transmission of Gram-negative bacteria has been reviewed in detail elsewhere. 3 Unlike MRSA and enterococci,
Enterobacteriaceae have a more fluid genome, mediated chiefly by the extensive carriage of conjugative plasmids that frequently carry antibiotic resistance genes as well as pathogenicity genes. The ability of antibiotic resistance genes to be transferred from environmental bacteria to medically relevant species of bacteria is well recognized.
Emergence of extended-spectrum β-lactamases (ESBLs)
Arguably the most important development of the last two decades in the field of antibiotic resistance is the emergence and spread of extended-spectrum β-lactamases (ESBLs) of the CTX-M group. 4 Careful work by a group in Paris has shown that CTX-M resistance genes are present on the chromosomes of at least three species of Kluyvera, environmental bacteria closely associated with the rhizosphere (the complex microbial community surrounding plant rootlets). The resistance gene is inducible when on the chromosome but, once mobilized on to a plasmid with insertion sequences ISEcp1 and IS903, becomes highly mobile among the Enterobacteriaceae. 5 CTX-M was first recognized in 1989 in an isolate from a cancer patient of E. coli which was resistant to third generation cephalosporins. It was located on an 85 kilobase conjugative plasmid and the enzyme was originally designated MEN-1. 6 Four major groups of genetically distinct but related genotypes of CTX-M have
and the genotyping of strains from the early 2000s, it seems most plausible that this gene emerged in the Indian subcontinent and has then spread throughout the world. 8 CTX-M 14 was first described in Enterobacteriaceae from Guangzhou in Southern China in 1998. 9 The study indentifying CTX-M 14 observed a very high rate (≥35%) of ESBL production among E. coli in Guangzhou and, by reasoning similar to that applied to CTX-M 15 in India, it is most likely that CTX-M 14 emerged in China or an adjacent country during the mid-1980s, when locally produced cefotaxime was very widely used in hospital practice.
Spread of ESBLs
The movement of people around the world is a major consideration in the spread of 
M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT
many countries in Asia on resistance rates, but the SMART study (which samples E. coli and where CTX-M-positive clinical isolates were much more prevalent in those whose birthplace was outside of mainland France. 20 A consequence of the very high rates of ESBL production among Enterobacteriaceae in Asian countries is that there is a substantial use of carbapenem antibiotics, which has resulted with time in the emergence of plasmid-mediated resistance to that family of drugs. Of the five widely encountered carbapenemase genes -IMP, KPC, NDM, VIM, and OXA-48 -this review concentrates on IMP, KPC, and NDM.
IMP carbapenemases
IMP carbapenemases, the first plasmid-mediated transferable carbapenemases to be recognized, emerged in Japan in the 1990s. 21 The carbapenemases, like the CTX-M ESBL enzymes, have a range of genotypes that are given sequential numbers (e.g. IMP-1, IMP-2, etc.), with each new carbapenemase differing from previously described genotypes by at least one amino acid. The first genotype described, IMP-1, is the most widely encountered M A N U S C R I P T 
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Arguably one of the most widely distributed carbapenemases in the world is K. Greece has also had a substantial problem with KPC for a number of years, and, very recently, Italy has moved from a situation where carbapenemase genes were carried by less than 5% of K. pneumoniae isolates to one where, in 2011, they were carried by 25-50% K.
pneumoniae isolates. 32, 33 This might be linked to Italy's position as one of Europe's heaviest M A N U S C R I P T 

Carbapenemase-producing Enterobacteriaceae in the UK
In the UK, all five major groups of carbapenemases, as well as rarer enzymes, have been reported by the reference laboratory. The UK picture is dominated by KPC, but most KPC-producing isolates were either from screening samples or from clinical specimens in northwest England. The next most frequently seen carbapenemase is NDM, which is distributed across the UK but with higher numbers in the London region. OXA-48 is also frequently encountered and many of these are attributable to episodes of cross-infection, particularly in intensive care units. I believe that the UK will see an increasing pressure in the future from imported NDM, which may, if not dealt with vigorously, cause local problems.
The currently endemic KPC in northwest England is being controlled and may yet be eradicated, but we will experience further pressure from imported cases. In my view, the UK should be especially alert to future importations of NDM-1 and IMP-4 from Asia. Moreover, OXA-48 may well become locally endemic, as its detection is extremely problematic.
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The environment and Gram-negative resistance
Faecal carriage by humans is a major source of MDR Gram-negative bacilli within the hospital environment and can be selected by antimicrobial therapy. Once MDR Gramnegative resistance genes become widespread in the community, the opportunity exists for bacteria to be more widely disseminated through the environment and establish a cyclical pattern of distribution. 3 River sediment has recently been shown to be a substantial reservoir of antibiotic resistance genes. 40 Using a metagenomic approach, the authors demonstrated that these were present both in culturable and unculturable bacteria. Even the use of level 3 sewage treatment in the UK does not prevent significant numbers of CTX-M-producing Enterobacteriaceae being released into the aquatic environment. 13 They can then be acquired by people engaged in water sports, as well by farm animals, which may explain the acquisition by dairy herds of CTX-M 14 and 15, the two most prevalent types in humans. Several factors driving antimicrobial use in medicine in both China and India need to be addressed urgently to reduce the overall selection pressure.
Aquaculture, including fish farming, is another aspect of environmental and agricultural usage of antibiotics that gives cause for concern. In Scandinavian countries, the use of antibiotics in aquaculture has been greatly reduced by the development of vaccines and alternative farming methods, but this is not true in warm water aquaculture where antimicrobials, especially quinolones, are extensively used. Chinese aquacultural production has risen from six million tons in 1990 to 32 million tons in 2008, when it represented 62% of world production. 42 The first study of antibiotic-resistant bacteria in farmed fish in China was published by Jaing et al. in 2012.
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Guangdong province (the Chinese province with the greatest production of farmed fish) and Surveillance is information for action: the only country yet to have successfully controlled carbapenemase-producing Enterobacteriaceae is Israel, which launched a concerted programme of screening and cohort isolation. 46 This level of intervention will be difficult to introduce in many parts of the world where there are weak laboratory facilities, poor infection control, and widespread prescribing of antibiotics. The threat for the future appears to come largely from the Asian region, where increasing wealth and intensification of both medical practice and farming results in increased usage of antibiotics. China's introduction of controls of antibiotic consumption is extremely welcome. Activity in India appears modest thus far. As
African nations become wealthier and more agriculturally intensive, we may expect the same pattern to be repeated. If we are to avoid squandering the valuable resource of antimicrobials, we must act globally.
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